What do you need to know about the Betadine Solution?
DENVER (AP) A new drug that can treat patients with COVID-19 in the United States has received approval for a trial in Colorado and other states.
The approval from the Food and Drug Administration was issued Tuesday, the company said in a statement.
The company said it was planning to test the Betarine Solution on patients in a two-week window starting in April.
It has received $100 million from the U.S. government to develop the drug.
The company has raised about $1 billion from investors including General Catalyst.
The drug, which costs about $80 a pill, will be administered through nasal or intramuscular injections.
Patients with COVI-19 should start taking the drug within two weeks of being vaccinated.
It is a combination of two antibiotics and a second drug called azithromycin that is approved for treating pneumonia and bronchitis.
The Betarate Solution is made by the Boston-based biotech firm Regeneron.
Its main product line is a pill for treating COVID that has been licensed to more than 200 other companies, according to the company.
The Betarase pill is approved to treat respiratory infections.
Patient advocates and lawmakers in states including California, New Jersey and Massachusetts have said they will push for more testing of the Betarease pill for the next several years to see whether it works as well.